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Abstract
Background: The process of wound healing consists of several well distinguishable and finely tuned phases. For
most of these phases specific proteins have been characterized, although the underlying mechanisms of regulation
are not yet fully understood. It is an open question as to whether deficits in wound healing can be traced back to
chronic illnesses such as diabetes mellitus. Previous research efforts in this field focus largely on a restricted set of
marker proteins due to the limitations detection by antibodies imposes. For mechanistic purposes the elucidation
of differences in acute and chronic wounds can be addressed by a less restricted proteome study. Mass
spectrometric (MS) methods, e.g. multi dimensional protein identification technology (MudPIT), are well suitable for
this complex theme of interest. The human wound fluid proteome is extremely complex, as is human plasma.
Therefore, high-abundant proteins often mask the mass spectrometric detection of lower-abundant ones, which
makes a depletion step of such predominant proteins inevitable.
Findings: In this study a commercially available immunodepletion kit was evaluated for the detection of low-
abundant proteins from wound fluids. The dynamic range of the entire workflow was significantly increased to 5-6
orders of magnitude, which makes low-abundant regulatory proteins involved in wound healing accessible for MS
detection.
Conclusion: The depletion of abundant proteins is absolutely necessary in order to analyze highly complex protein
mixtures such as wound fluids using mass spectrometry. For this the used immunodepletion kit is a first but
important step in order to represent the entire dynamic range of highly complex protein mixtures in the future.
Background
In times of nutritious superabundance obesity becomes
a serious concern. Thus, almost 6% of the world’s popu-
lation is suffering from diabetes mellitus [1]. Nearly all
types of diabetes mellitus show numerous long-term
consequences, such as a heart attack or apoplectic
stroke. Diabetics often tend to build ulcers on lower
extremities because of arterial obstructive diseases.
These wounds show an abnormal wound healing pro-
cess, but the reason for this dysfunction is still unknown
today. Several important components like growth factors
or cytokines etc. were characterized recently, which
enable a classification of the wound healing process in
different phases [2,3]. Nevertheless, the underlying
mechanisms in wound healing disturbance have not yet
been answered completely. Consequently, understanding
of the factors involved and their interactions, particu-
larly on the biomolecular level, is of great interest.
Some common biological and chemical methods, such
as ELISA or 2 D gel electrophoresis, are available for
the analysis of protein mixtures nowadays, but they
require either an accurate knowledge of the target pro-
teins or they offer a limited dynamic range.
Mass spectrometry (MS) evolved as a powerful tool
for the analysis of complex protein mixtures. Multidi-
mensional protein identification technology (MudPIT)
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ments in proteome analysis [4,5].
MudPIT is a gel-free approach and combines two-
dimensional liquid chromatography with electrospray-
ionization (ESI)-MS/MS, which comprises a relatively
large dynamic range of 4 orders of magnitude. Several
hundred proteins can be generated within 24 h employ-
ing this technology.
We utilized MudPIT for the proteomic analysis of
acute and diabetic wound fluid to achieve a deeper
insight into wound healing processes in the future. Due
to the large nescience of the proteins involved and their
abundance in wound fluids, the work with exudates is
based on the knowledge already gained from human
plasma. More than 90% of the human plasma proteome
consists of highly abundant proteins, which obscure the
identification results [6,7]. It has been reported that
these abundant proteins are also present in wound fluid
and that their depletion is necessary for the identifica-
tion of proteins present in lower concentrations, which
are supposed to have a significant influence in disturbed
wound healing [8]. Nevertheless, the dynamic range of a
consecutive depletion and mass spectrometric approach
was not investigated and low-abundant proteins have
not been detected. Therefore, the goal of this study was
to evaluate the biological handling of wound fluids for
the depletion of the 20 most-abundant proteins, and the
mass spectrometric detection of low-abundant regula-
tory proteins involved in wound healing.
Methods
Collection of Wound Fluid Samples
As part of the inpatient treatment of acute and chronic
wound polyvenylalcohol (PVA) sponges were applied to
the wound bed to withdraw the exudates. Soaked
sponges were then moistened with 2 ml protease inhibi-
tor using Roche Complete tablets containing a protease
inhibitor cocktail of serine, cysteine and metalloprotease
inhibitors (Penzberg, Germany) dissolved in saline and
carefully centrifuged at 125 × g to collect the wound
fluid. This step was repeated twice. One tablet was dis-
solved in 50 ml saline solution. Cell debris was removed
by centrifugation at 14.000 × g for 5 min from the
supernatant, which was snap-frozen with liquid N2 and
stored at -80°C until further analysis. Samples were col-
lected from three patients showing acute wounds and
from three chronic wound patients with diabetes melli-
tus type 2. The protein content of the exudates was
determined to be 20-50 mg/ml by bicinchoninic acid
(BCA) assay (BCA Protein Assay Kit, Pierce Chemicals,
Rockford, IL) and samples were diluted to yield a final
protein content of 15 mg. The ethics committee of the
Ruhr-University Bochum, Germany approved the study
protocol.
Immunodepletion
Depletion of the 20 most abundant proteins in acute and
chronic wound fluids
In order to become familiarized with depletion condi-
tions and working routines for wound fluid we tested
the depletion efficiency of the ProteoPrep® 20 Plasma
Immunodepletion Kit (Sigma-Aldrich, Steinheim,
Germany). The ProteoPrep® 20-Kit depletes the 20 most
abundant proteins in human plasma, listed in Table 1.
These proteins, which occur in acute and chronic
wound fluid, were removed with this kit according to
the manufacturer’s instructions.
The ProteoPrep® 20 device handles volumes of about
8 µl of serum (diluted to about 100 µl working volume)
per run. We decided to use 1 ml of wound fluid (15 mg
protein content) in 10 consecutive runs, combine and
concentrate the depleted fractions and proceed with a
11th final depletion step to achieve 99% depletion as
suggested by the manufacturer. The flow-through pro-
teins, i.e. the low concentrated depleted ones, were acet-
one precipitated and resuspended in 25 mM NH4HCO3.
The bound proteins, i.e. the depleted 20 most abundant
ones, were TCA (Trichloroacetic acid) precipitated and
resuspended in 25 mM NH4HCO3 as well. 1D-SDS-
PAGE and MudPIT analyzed the resulting depleted con-
centrated fractions.
Gel electrophoresis
Wound fluid samples (20 µg each) were incubated for
10 min at 60°C in presence of 2 times sample buffer
(0.5 M Tris-HCL, pH 6.8, 3% w/v SDS, 10% v/v gly-
cerol,0.5% v/v 2-mercaptoethanol, and bromophenol
blue). Samples were loaded onto a 15% sodium dodecyl
sulfate-polyacrylamide gel (SDS-PAGE) and run at a
constant voltage of approximately 100 V. Silver staining
was applied to visualize proteins.
Measurement of IL6 concentration
The level of Interleukin-6 concentrations in crude
wound exudates and the corresponding depleted flow
through was measured by a specific sandwich enzyme
Table 1 Twenty most-abundant proteins depleted by
ProteoPrep® 20
Albumin a1-Acid-Glycoprotein
IgG Ceruloplasmin
IgA Apolipoprotein A-I
IgM Apolipoprotein A-II
IgD Apolipoprotein B
Transferrin Complement C1q
Fibrinogen Complement C3
a2-Macroglobulin Complement C4
a1-Antitrypsin Plasminogen
Haptoglobin Prealbumin
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assay (ELISA) (R&D, Wiesbaden, Germany) following
the standard protocol provided. The concentrations
were calculated using a standard curve that was created
by serially diluted IL-6 standard protein (R&D, Wiesba-
den, Germany) by the Elx808 Microplate Reader (Bio-
Tek, Bad Friedrichshall, Germany) and Excel software
(Microsoft, Unterschleißheim, Germany).
MudPIT
A quaternary Ultimate High performance liquid chro-
matography (HPLC)-pump (Dionex, Amsterdam, Neth-
erlands) was connected to a Thermo LTQ XL ion trap
mass spectrometer from Thermo Fisher Scientific Inc.
(San Jose, CA).
600 µg of each depleted sample were digested enzymati-
cally with the proteases trypsin (sequencing grade, Promega,
Madison, WI) and chymotrypsin (modified sequencing
grade, Princeton Separations Inc., Adelphia, NJ).
The peptides generated were loaded onto a biphasic
micro capillary (diameter (d) = 100 µm) which was
packed with 10 cm of Luna C18 reversed phase (RP)
Material, 5 cm strong cation exchange (SCX) material
(Phenomenex, Germany) and finally with 6 cm of Luna
C18 RP material. The effective flow rate of the column
was set to 150 - 250 nL/min and a spray voltage of
1.8 kV was supplied. The LTQ XL was operated via
instrument method files in the Sequence Setup window
of Xcalibur. The heated desolvation capillary was set to
180 °C. Chromatography was performed as described
elsewhere [5], using a 20 step gradient program including
salt steps with 5, 10, 15, 20, 25, 30-100% 250 mM
Ammonium acetate (NH4Ac) and 33, 50, 75% 1.5 M
NH4Ac.
A full MS scan between 400 and 2000 m/z for the
precursor ion was applied followed by full MS/MS scans
of the three most intense ions from the preceding MS
scan.
Data Analysis
To interpret the MS/MS data we used the SEQUEST
algorithm implemented in Bioworks 3.3.1. Data were
searched against the human Swiss-Prot database release
54. All accepted results had a ΔCn value of at least 0.08
and singly, doubly and triply charged peptides had to be
partially tryptic or chymotryptic with XCorr > 1.8, 2.5
or 3.5 and a precursor mass accuracy of at least 2.5
atomic mass units (amu). Fragment ion tolerance was
set to 1 amu. Methionine oxidation was considered a
variable modification. The rank of the preliminary score
(RSp) was set ≤ 10.
A protein was considered as present in the mixture
when two or more unique peptides were identified by
the previous criteria. The lists of the identified proteins
were generated with DTAselect 1.9. False positive rate
was less than 2% estimated by a reverse database search.
The false discovery rate was calculated by dividing the
absolute number of hits from this reversed database
search by the sum of hits from both database searches
(reversed database and actual database).
The depletion efficiency of high abundant proteins in
wound fluids was estimated comparing the spectrum
count percentages of these proteins in the enriched
sample, called bound fraction, and the depleted sample,
in the following named as flow-through fraction. Spec-
trum count is given as the number of successful MS/MS
experiments. Percentages were calculated dividing the
spectrum count of each protein by a hundredth of the
total spectrum count of each experiment.
Results
Depletion of high-abundant proteins in acute and chronic
wound fluids
We monitored the degree of depletion of the 20 most
abundant proteins in the bound fraction and the flow-
through fraction, by using1 D - S D SP A G Ea n dM u d P I T .
The bound fraction should contain the majority of those
20 proteins, whereas the flow-through supposedly con-
tains only the low abundant proteins and only trace
amounts of the 20 high abundant proteins. It seems very
likely and the results from Fernandez et al. indicate that
the 20 high-abundant proteins are also present in wound
fluids [8]. However, it was never shown that their amount
and distribution in human wound fluids are suitable for
the ProteoPrep® 20 Kit, which consequently yields identi-
fication of low-abundant proteins. 1D-SDS-PAGE analy-
sis of the bound fraction exhibits a successful depletion
of the high-abundant proteins in the mass range greater
than 25 kDa, when using the ProteoPrep® 20 Kit (Figure
1). Lanes 8-10 reflect the bound fraction from acute and
diabetic wound exudates, respectively. Spot pattern of the
high-abundant proteins in lanes 8-10 are nearly identical,
therefore we suppose, that the 20 most abundant pro-
teins have a predominant occurrence in human wound
fluid similar to human plasma (data not shown). For
further evaluation of this aspect we performed a MudPIT
analysis of the bound protein fraction from a diabetic
wound fluid sample (Table 2).
Proteins in the flow-through, lanes 4-6, revealed dif-
ferences in spot pattern compared to the bound fraction,
especially in the intensity of spots in higher mass ranges.
Based on these qualitative results, we assume that the
depletion of the 20 most abundant proteins was success-
ful. We validated this assumption by MudPIT analyses.
MudPIT analyses
High-abundant proteins
The MudPIT analysis of the bound protein fraction
revealed 17 of the 20 most abundant proteins, enriched by
Steinsträßer et al. BMC Research Notes 2010, 3:335
http://www.biomedcentral.com/1756-0500/3/335
Page 3 of 9the kit resin (Table 2). Overall, more than 20 entries are
shown in Table 2, contributed to polyclonal antibodies in
the ProteoPrep® 20 Kit, which do not discriminate different
isotype subclasses, such as IGHG1_Human, IGHG2_
Human or IGHG3_Human. 14 of these proteins were
found with more than one peptide in the bound fraction.
Due to quantitative evaluation of the bound fraction, the
two peptides per protein criteria were not applied for the
high-abundant proteins. Thus, three proteins from the
depletion list of the kit were identified with only one pep-
tide per protein in this sample.
Furthermore, we were able to deplete three additional
high-abundant proteins, two from the complement sys-
tem (CO5_HUMAN, C1S_HUMAN) and one immuno-
globulin (KAC_HUMAN), due to known protein-protein
interactions or cross reactivity. Merely IgD, complement
C4 and complement C1q could not be detected by Mud-
PIT analysis. However, it is possible that these proteins
are either not expressed in human wound fluid or down-
regulation in the present state avoids their detection.
Furthermore these proteins are in the lower concentra-
tion range of the 20 most abundant proteins, therefore
masking of these proteins might be possible, or irreversi-
b l eb i n d i n go nt h ek i tr e s i nc o u l db ear e a s o nf o rt h e s e
results. These results show that 17 of the most abundant
plasma proteins also occur in human wound fluids.
In total, 78 proteins (sequence count > 1) were identi-
fied in the bound fraction of the MudPIT experiment.
The abundant proteins retained the additional 61 pro-
teins. However, this effect is most likely due to protein-
protein interaction and unspecific binding, which does
not significantly influence the identification rate in the
MudPIT experiments of the depleted fraction. Almost
70% of these additional proteins were identified in the
flow-through fraction as well. According to the low num-
ber of spectral counts from these unspecifically bound
proteins in the bound fraction, the analysis of the flow-
through fraction is not largely affected. Spectrum count
is defined as the number of successful MS/MS spectra. It
is related to the protein amount in the sample and pro-
teins can be quantified relative to one other [9].
Low abundant proteins
We tested the ProteoPrep® 20 Plasma Immunodepletion
Kit with three chronic and three acute wound fluid sam-
ples. To demonstrate a successful depletion of these 20
high-abundant plasma proteins in wound fluids, we
applied MudPIT analyses to the flow-through fractions
of the acute and chronic wound fluid samples. After
MudPIT experiments we monitored the amount of
high-abundant proteins in the flow-through and quanti-
fied them by spectral counting.
We focused on the degree of depletion. In all samples,
the majority of the high-abundant proteins identified
exhibited relatively low spectral counts compared to the
total number of spectral counts obtained for such sam-
ples. Usually, the spectral count percentage of the 20
high-abundant proteins is below 1% for each protein
(Table 3). Some proteins showed spectral counting per-
centages above 1% such as albumin and apolipoprotein
A1. Six of the 20 most abundant proteins were not iden-
tified in the depleted fractions, neither in the chronic
samples nor in the acute ones.
Overall, 355 unique proteins (data not shown) were
identified by the MudPIT experiments in the depleted
fractions. Since this work is technology driven, it is
beyond the scope of this work to analyze these proteins
Figure 1 1D-SDS-PAGE (silver stained). Bound and flow-through (FT) proteins derived from diabetic and acute wound fluids. Lane 1: Human
serum albumin (HSA) (2 µg), 2: MW marker, 3: empty, 4: FT proteins acute, 5-6: FT proteins diabetic (two different patients), 7: empty, 8-10:
bound proteins (8: acute; 9-10: diabetic).
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this depletion strategy, we briefly analyzed the list of
identified proteins, which are usually considered as low
abundant. Anderson and Anderson demonstrated the
difficulties in mass spectrometric detection of very low
concentrated human plasma proteins [6]. For example
interleukins and interferons exist in pg/ml concentra-
tions in human plasma and hence are considered as low
abundant. With the depletion strategy we were able to
detect low-abundant proteins such as Interleukin-16
(Q14005|IL16_HUMAN) and Interleukin 6 (P05231|
IL6_HUMAN) (Figure 2). Interleukins play a very
important role in wound healing mechanisms, especially
Interleukin-16 and Interleukin-6, which are supposed to
have proinflammatory effects [10,11]. Furthermore,
matrix metalloproteinases (MMP) 1, 2, 3, 8 and 9 could
be identified. Exemplified spectra of the respective pep-
tides are shown in Figure 2. MMPs are mainly involved
in the degradation of extracellular matrix proteins. In
human plasma the amount varies in the pg/ml range,
thus they are considered as low abundant. MMPs are
largely described as up regulated in several types of
wound tissue, or fluids and therefore discussed as poten-
tial biomarker [12-16].
Since Anderson and Anderson determined the pro-
teome profile from human plasma, its values might not
Table 2 Detection of the 20 most-abundant proteins of the bound fraction
Protein code Spectral count Sequence count Sequence coverage [%]
P02768|ALBU_HUMAN 2119 (51.68) 87 43
P01009|A1AT_HUMAN 307 (7.49) 29 36
P02763|A1AG1_HUMAN 230 (5.61) 18 34
P19652|A1AG2_HUMAN 31 (0.76) 10 27
P01857|IGHG1_HUMAN 120 (2.93) 26 32
P01859|IGHG2_HUMAN 118 (2.88) 22 28
P01860|IGHG3_HUMAN 45 (1.10) 10 17
P02647|APOA1_HUMAN 25 (0.61) 10 23
P02652|APOA2_HUMAN 1 (0.02) 1 9
P04114|APOB_HUMAN 100 (2.44) 28 6
P01876|IGHA1_HUMAN 19 (0.46) 6 19
P01877|IGHA2_HUMAN 15 (0.37) 6 20
P02671|FIBA_HUMAN 25 (0.61) 7 6
P02675|FIBB_HUMAN 26 (0.63) 12 19
P02679|FIBG_HUMAN 25 (0.61) 12 14
P02787|TRFE_HUMAN 61 (1.49) 11 7
P01023|A2MG_HUMAN 47 (1.15) 25 17
P01871|MUC_HUMAN 3 (0.07) 2 6
P00738|HPT_HUMAN 55 (1.34) 14 17
P00450|CERU_HUMAN 114 (2.78) 26 14
P02766|TTHY_HUMAN 322 (7.85) 9 24
P00747|PLMN_HUMAN 2 (0.05) 1 1
P01024|CO3_HUMAN 268 (6.54) 52 18
Additionally detected
P01834|KAC_HUMAN 17 (0.41) 2 16
P01031||CO5_HUMAN 3 (0.07) 3 2
P09871|C1S_HUMAN 2 (0.05) 2 4
Not detected
P02746|C1QB_HUMAN -- -
P02747|C1QC_HUMAN -- -
P01880|IGHD_HUMAN -- -
P01880|CO4_HUMAN -- -
This table shows the identification rate of the 20 most-abundant proteins that bound to the kit’s resin after depletion with the ProteoPrep® 20 Plasma
Immunodepletion Kit. Percentage of the spectral count is given in brackets
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ELISA assay for IL-6 was established. An IL-6 concen-
tration of 29 ng/ml was measured within the depleted
wound fluid sample, while it was below background
level within the captured high-abundant protein
fraction.
A tt h eh i g h - a b u n d a n c ee n dt h e2 2m o s ta b u n d a n t
proteins comprise more than 99% of all proteins in
human plasma, whereas human serum albumin itself
comprises 65% [6,17]. We assume that analogous to
plasma high-abundant proteins were removed by the kit.
15 mg protein per undepleted wound fluid sample was
applied to the kit resin. After depletion the samples
yield a protein concentration of at most 1 mg in the
flow-through fraction, according to the BCA assay. BCA
assays, performed before anda f t e rd e p l e t i o nw i t ht h e
ProteoPrep® kit, indicated a reduction of the total pro-
tein amount of almost 93%. Consequently, effective
depletion of high abundant proteins facilitates the iden-
tification of low abundant proteins.
Discussion
Diabetic patients often tend to build ulcers on their
lower extremities, whereas the pathophysiology of the
impaired wound healing in these patients remains
unclear. However, there are many expensive treatment
options (e.g. dressings, growth factors) for these wounds
available in clinics. Unfortunately, the importance for
Table 3 Evaluation of the 20 most abundant proteins in the flow-through fractions
Protein code DWF 1 DWF 2 DWF3 AWF 1 AWF 2 AWF3
Spectral count total 12386 6559 9027 8995 6318 7819
P02768|ALBU_HUMAN 126 (1.02) 7 (0.11) 119 (1.32) 4 (0.07) 119 (1.88) 33 (0.42)
P01009|A1AT_HUMAN 3 (0.07) - - 1 (0.01) 7 (0.11) 196 (2.51)
P02763|A1AG1_HUMAN 27 (0.21) - - 61 (0.68) - 71 (0.91)
P19652|A1AG2_HUMAN 1 (0.01) - - - - 55 (0.70)
P01857|IGHG1_HUMAN 30 (0.24) - 40 (0.44) - 37 (0.59) -
P01859|IGHG2_HUMAN 23 (0.19) 6 (0.09) 29 (0.32) 2 (0.02) 34 (0.54) 16 (0.20)
P01860|IGHG3_HUMAN 15 (0.12) 5 (0.08) 4 (0.04) - 14 (0.22) 4 (0.05)
P02647|APOA1_HUMAN 17 (0.14) 1 (0.02) 9 (0.10) - 30 (0.48) 142 (1.82)
P02652|APOA2_HUMAN 1 (0.01) - - - 1 (0.02) 1 (0.01)
P04114|APOB_HUMAN 21 (0.17) 1 (0.02) 18 (0.20) 2 (0.02) 43 (0.68) 32 (0.41)
P01876|IGHA1_HUMAN - - 6 (0.07) - - -
P01877|IGHA2_HUMAN ----- -
P02671|FIBA_HUMAN 58 (0.47) 50 (0.76) 33 (0.37) 2 (0.02) 50 (0.79) 13 (0.17)
P02675|FIBB_HUMAN 12 (0.10) 1 (0.02) 17 (0.19) 3 (0.03) 4 (0.06) -
P02679|FIBG_HUMAN 2 (0.05) 5 (0.08) 6 (0.07) 1 (0.01) 3 (0.05) -
P02787|TRFE_HUMAN 1 (0.01) - 8 (0.09) - 10 (0.16) 1 (0.01)
P01023|A2MG_HUMAN 11 (0.09) 5 (0.08) 50 (0.55) 3 (0.03) 26 (0.41) 4 (0.05)
P01871|MUC_HUMAN - - - - - -
P00738|HPT_HUMAN 60 (0.49) 8 (0.12) 5 (0.06) 2 (0.02) 22 (0.35) 52 (0.67)
P00450|CERU_HUMAN 3 (0.02) - 1 (0.01) - - -
P02766|TTHY_HUMAN - - 71 (0.79) - 164 (2.60) 16 (0.2)
P00747|PLMN_HUMAN - - 1 (0.01) - - -
P01024|CO3_HUMAN 44 (0.36) 10 (0.15) 68 (0.75) - 30 (0.47) 3 (0.04)
P01834|KAC_HUMAN 4 (0.03) 11 (0.17) 47 (0.52) 1 (0.01) 23 (0.36) -
P01031||CO5_HUMAN 4 (0.03) 1 (0.02) 20 (0.22) 2 (0.02) 14 (0.22) 19 (0.24)
P09871|C1S_HUMAN 1 (0.01) - 10 (0.11) - 6 (0.09) 1 (0.01)
P02746|C1QB_HUMAN ----- -
P02747|C1QC_HUMAN ----- -
P01880|IGHD_HUMAN ----- -
P01880|CO4_HUMAN ----- -
Three diabetic (DWF) and three acute wound fluids (AWF) were analyzed after depletion with the ProteoPrep® 20 Plasma Immunodepletion Kit. Spectral counts
were standardized in respect to the overall number and percentages are given in brackets.
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efit for patients on the molecular level is small. There-
fore, central questions about impaired wound healing,
especially the biomolecular aspects remain open.
Knowledge of the human wound fluid proteome might
help to address some of the questions, since new meth-
ods and technology such as new developments in mass
spectrometry are constantly emerging.
Figure 2 MS/MS spectra of a) MMP1 (Peptide mass: 876 m/z), XCorr 5.19 b) MMP2 (794 m/z), XCorr: 4.30 c) MMP3 (888 m/z), XCorr:
4.07 d) MMP8 (926 m/z), XCorr: 5.11 e) MMP9 (879 m/z), XCorr: 5.01 f) IL16 (627 m/z), XCorr: 3.90 and g) IL6 (1105 m/z), XCorr 4.11;
all peptides are doubly charged.
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plasma a very complex proteome, but very few proteins
are investigated in detail until now [3,12]. Since large-
scale analyses have not yet elucidated the wound fluid
proteome, the human plasma proteome is the next best
choice to correlate information about protein composi-
tion or function. It is feasible that abundant proteins in
plasma play a substantial and comparable role in human
wound fluid, too. Nevertheless, it has not been proven
in detail that immunodepletion strategies applied to
human serum or plasma are comparably efficient for
human wound fluid.
High-abundant protein species have a huge impact on
the dynamic range in mass spectrometric analysis by
masking low-abundant proteins and thereby reduce the
identification potential. This makes depletion steps of
high-concentrated proteins essential. The ProteoPrep®
20 Plasma Immunodepletion Kit (Sigma-Aldrich, Stein-
heim, Germany) depletes the 20 most-abundant proteins
in human plasma. We have applied this kit for the use
on wound fluids and showed qualitatively by 1D-SDS-
PAGE and quantitatively by MudPIT experiments that
depletion was successful. MudPIT analysis of the bound
fraction revealed 17 of the 20 most-abundant proteins
from human plasma to be present in wound fluid. It can
be assumed that these proteins are not responsible for
wound healing dysfunction, therefore techniques have to
be developed, which make lower abundant proteins
accessible. These proteins are usually addressed by
ELISA, e.g. for the ratio estimation of MMPs and their
corresponding endogenous inhibitors, the tissue inhibi-
tors of metalloproteinases (TIMPs). This ratio has to be
in balance for an undisturbed wound healing process.
Investigations showed that decreased MMP3 and MMP9
levels during therapy correlate with positive wound heal-
ing outcomes [18]. These facts are just an indication for
patients’ treatment and relevant investigation methods,
b u tt h e yh a v et ob ee x p a n d e du p o nt oe l u c i d a t et h e
chronic wound problem.
For mass spectrometric analysis of low abundant pro-
teins in wound fluids, depletion strategies for high
abundant proteins are necessary. We tested the Proteo-
Prep® Plasma 20 immunodepletion kit for the use of
protein depletion in chronic and acute wound fluids.
The quality of depletion using the immunodepletion kit
was assessed by comparing spectrum count percentages
of high abundant proteins in the enriched and the
flow-through fractions, collected separately. SDS-PAGE
separations (Figure 1) and BCA assay measurements
indicate a substantial decrease in the amount of pro-
teins in the depleted samples. MudPIT experiments
prove that lower protein content is related to the deple-
tion of the most abundant proteins. The bound fraction
contained 17 of the 20 most abundant proteins, while
three were not detectable. In the flow-through fractions
of three acute and three diabetic samples, six high-
abundant proteins could not be identified e.g. comple-
ment system proteins and immunoglobulins. The
majority of the detected abundant proteins in the
depleted samples show a spectrum count percentage of
less than 1% each, compared to the overall count.
These concentrations of the 20 most-abundant proteins
in the depleted fraction are for future investigations tol-
erable. Due to the successful depletion, the accessible
dynamic range should be expanded. So far mass spec-
trometric approaches including 2D-PAGE or MudPIT
comprise a dynamic range of 10
2-10
4 [5,6]. In this
study we determined a dynamic range of at least 5 to 6
orders of magnitude, since we identified low-abundant
proteins such as MMP1, MMP2, MMP3, MMP8,
MMP9, IL6 and IL16 (Figure 2). Interestingly, Anderson
and Anderson, and Kilpadi et al. presented concentra-
tions for these proteins in human plasma or swine
serum respectively in the order of pg/ml [6,19], whereas
our data showed significantly higher values for IL6 with
20-40 ng/ml in wound fluids. Similar observations were
obtained by Kilpadi et al. who investigated wound fluids
from patients treated with the vacuum assisted closure
therapy [18]. They reported concentrations between
151-666 ng/ml for MMP3 and 1,593-5,649 ng/ml for
MMP9 in these fluids. The results lead to the assump-
tion that the protein pool in human wound fluids dif-
fers at least in respect to protein concentration
compared to human plasma. The removal of high-
abundant proteins is crucial for a detailed analysis of
low-abundant proteins in order to create a comprehen-
sive protein profile of chronic and acute wound fluids
in the future. This facilitates a deeper insight in the
physiology and pathophysiology of wound repair which
will hopefully contribute towards establishing new ther-
apy strategies.
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